Leniolisib
ATC L03AX22 · 5 markets · 8 records
US 3 records · 3 strengths
AU 2 records · 2 strengths
- 85.26 mgtabletJOENJA leniolisib (as phosphate) 70 mg film coated tablets bottle
Records without a stated strength · 1 Joenja
GB 1 records · 1 strengths
- 70 mgtabletJoenja
CA 1 records · 1 strengths
- 70 mgtabletJoenja
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Joenja
| Strength / form / release | US | GB | CA | AU | EU |
|---|---|---|---|---|---|
| 70 mg tablet | Joenja | Joenja | Joenja | ||
| 85.26 mg tablet | JOENJA leniolisib (as phosphate) 70 mg film coated tablets bottle | ||||
| 50 mg tablet | Joenja | ||||
| 40 mg tablet | Joenja | ||||
unknown | Joenja | Joenja |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.